Table 2.
Variable | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | IDF criteria for the metabolic syndrome | Normal range |
---|---|---|---|---|---|---|---|---|---|---|
Sex | Male | Male | Male | Male | Male | Male | Male | Female | ||
Age (years) | 24 | 31 | 27 | 29 | 25 | 26 | 27 | 32 | ||
CYP19A1 mutation(s) | P.R375C | P.R365Q | c.IVS5-3C>A | P.E210K | P.M127R; P.R375H | c.312–334del; C.IVS9 + 1G>T | P.R375H | p.A306_S314dup | ||
Body mass index (BMI) | 32.5 | 27.6 | 30.9 | 27.6 | 35.8 | 29.3 | 25.7 | <25 | ||
Waist circumference (cm) | 124 | 122 | 121 | 102 | 131 | ≥ 94 (men); ≥ 80 (women)* | ||||
Blood pressure (mmHg) | 158/72 | Normal | 125/80 | 125/75 | 130–145/80–100 | ≥ 130/ ≥ 85 | ||||
Fasting glucose (mmol/l) | 3.9 | 4.9 | Normal | 10 | 5.6 | 4.1 | 5.4 | 6.1 | ≥ 5.6 | |
Fasting insulin (μIU/ml) | 52 | 22 | 94 | 42 | 62.8 | 9.89 | 57 | 5–25 | ||
HOMA for insulin resistance | 9 | 4.8 | 3.6 | 41.7 | 10.6 | 11.3 | 2.4 | 15.5 | <2.5 | |
Hemoglobin A1c (%) | 7.4 | 8.3 | 5.5 | 5.6 | 6.7 | 4.5–6 | ||||
Total cholesterol (mmol/l) | 6.2 | 7.9 | 4.6 | 4.6 | 5.6 | 5.6 | 6.4 | 5.9 | <5.2 | |
LDL cholesterol (mmol/l) | 3.6 | 5.4 | 2.9 | 2.8 | 3.4 | 3.7 | 4.2 | 3.6 | <3.3 | |
HDL cholesterol (mmol/l) | 0.93 | 1.11 | 0.54 | 0.8 | 0.82 | 0.98 | 1.04 | 1.4 | <1.03 (men); <1.29 | |
Triglycerides (mmol/l) | 3.6 | 3.4 | 3 | 2.2 | 2.9 | 1 | 2.2 | 2 | (women) ≥ 1.7 | |
Aminoleucine transferase (U/l) | Normal | 195 | 104 | 72 | 41 | <37 | ||||
Aspartate aminotransferase (U/l) | 74 | 108 | 60 | 24 | 38 | <40 | ||||
Liver steatosis | Yes | Yes | Yes | Yes | Yes | |||||
Reference | Morishima et al., 1995 | Carani et al., 1997 | Herrmann et al., 2002 | Maffei et al., 2004 | Maffei et al., 2007 | Lanfranco et al., 2008 | Baykan et al., 2013 | Gagliardi et al., 2014 | Alberti et al., 2005 |
The waist circumference cutoff is for white people of European origin; IDF denotes International Diabetes Federation, HOMA homeostasis model assessment, LDL low-density lipoprotein, and HDL high-density lipoprotein.